FERTIN PHARMA A/S: Financial statements 2017
CVR: 25834844
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 867,662,000 and a net result of DKK 106,353,000 compared with DKK 100,073,000 the year before. That is an increase of 1.4% compared with the year before. The profit margin was 12.3%. Equity in the 2017 report amounted to DKK 770,467,000. The solvency ratio was 47.3%. The company had 572 employees in the financial year.
- Revenue
- DKK 867,662,000
- Gross Profit
- DKK 208,458,000
- Profit/Loss
- DKK 106,353,000
- Equity
- DKK 770,467,000
- Total Assets
- DKK 1,627,578,000
- Employees
- 572
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 867.7M | 208.5M | 106.4M | 770.5M | 572 |
| 2016 | 855.7M | 546.5M | 100.1M | 659.6M | 530 |
| 2015 | 800.7M | 467.8M | 64M | 560.9M | 543 |
| 2014 | 694.1M | 419.5M | 42.2M | 495M | 446 |
Official annual report
Keep an eye on FERTIN PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
FERTIN PHARMA A/S has published its annual report for 2016. Revenue came to DKK 855,745,000, and the net result was DKK 100,073,000.
As of January 17, 2017, Claus Bagger-Sørensen has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Rikke Kjær Nielsen has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Manfred Scheske has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Nikhilesh Singh has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Thomas Werner has joined the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Erik Gregers Hansen has left the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Svend Andersen has left the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Steen Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.
As of January 17, 2017, Marianne Kock has left the board of directors of FERTIN PHARMA A/S.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.